FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3 Study of Tivantinib in Second-Line Hepatocellular Carcinoma
March 22, 2016
ArQule Reports Fourth Quarter and Full Year 2015 Financial Results
February 29, 2016
ArQule to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016
February 15, 2016
ArQule to Present at Upcoming Investor Conferences
February 04, 2016
ArQule Provides Proprietary Pipeline Update for AKT Inhibitors
January 28, 2016
ArQule Presents Clinical Biomarker Data From Phase 2 Study and Ongoing Phase 3 METIV-HCC Study of Tivantinib in Second-Line Hepatocellular Carcinoma at the 2016 Gastrointestinal Cancers Symposium
January 25, 2016
ArQule Announces Orphan Drug Designation in Cholangiocarcinoma and Clinical Update for ARQ 087
December 15, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here